Development of adjuvanted HIV vaccines tailored for early life: immunologic rationale, clinical experience, and future directions.

Smolen KK, De Paris K, Angelidou A, Martin TM, van Haren SD, Levy O

Open source

DOI
10.1097/coh.0000000000001068
Published
2026 Sep 2
Container
Current opinion in HIV and AIDS
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/coh.0000000000001068,
  title = {Development of adjuvanted HIV vaccines tailored for early life: immunologic rationale, clinical experience, and future directions.},
  author = {Smolen KK and De Paris K and Angelidou A and Martin TM and van Haren SD and Levy O},
  year = {2026},
  journal = {Current opinion in HIV and AIDS},
  doi = {10.1097/coh.0000000000001068},
  url = {https://doi.org/10.1097/coh.0000000000001068}
}

RIS

TY  - JOUR
TI  - Development of adjuvanted HIV vaccines tailored for early life: immunologic rationale, clinical experience, and future directions.
AU  - Smolen KK
AU  - De Paris K
AU  - Angelidou A
AU  - Martin TM
AU  - van Haren SD
AU  - Levy O
PY  - 2026
JO  - Current opinion in HIV and AIDS
DO  - 10.1097/coh.0000000000001068
UR  - https://doi.org/10.1097/coh.0000000000001068
ER  - 

APA

KK, S., K, D. P., A, A., TM, M., SD, V. H., & O, L. (2026). Development of adjuvanted HIV vaccines tailored for early life: immunologic rationale, clinical experience, and future directions.. Current opinion in HIV and AIDS. https://doi.org/10.1097/coh.0000000000001068

Source records